Emergence of a novel SARS-CoV-2 strain in Southern California, USA

  title={Emergence of a novel SARS-CoV-2 strain in Southern California, USA},
  author={Wenjuan Zhang and Brian D. Davis and Stephanie S Chen and Jorge M Sincuir Martinez and Jasmine T. Plummer and Eric Vail},
  • Wenjuan Zhang, B. Davis, +3 authors E. Vail
  • Published in medRxiv 2021
  • Medicine
Since October 2020, novel strains of SARS-CoV-2 including B.1.1.7, have been identified to be of global significance from an infection and surveillance perspective. While this strain (B.1.1.7) may play an important role in increased COVID rates in the UK, there are still no reported strains to account for the spike of cases in Los Angeles (LA) and California as a whole, which currently has some of the highest absolute and per-capita COVID transmission rates in the country. From the early days… Expand
Genomic Surveillance of SARS-CoV-2 in Erie County, New York
This work highlights the importance of widespread, regional surveillance of SARS-CoV-2 across the United States, and indicates both multiple introductions and community spread in lineages circulating in Western New York. Expand
SARS-CoV-2 Viral Variants-Tackling a Moving Target.
In this issue of JAMA, Zhang and colleagues1 report the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in Southern California that accounted for 44% (37 ofExpand
Response to mutation and variants of the SARS-CoV-2 gene
Since the COVID-19 pandemic, our society has come to understand that the cause is the Corona Virus (2019-nCoV) or more popularly known as the severe acute respiratory syndrome coronavirus 2Expand
Identification and trajectory of growth of concerning SARS-CoV-2 variants in Houston, Texas, January through April 2021 based on 11,568 genome sequences
In the aggregate, the study shows the occurrence of a diverse array of concerning SARS-CoV-2 variants circulating in a major metropolitan area, documents B.1.1-1.7 as the major cause of new cases in Houston and heralds the arrival and spread of B.617 variants in the metroplex. Expand
Executive Summary of SARS-CoV-2 novel variants
At just over one year into the COVID-19 pandemic, evolution of SARS-CoV-2 has generated viral variants that differ in their genetic sequence from the strain first detected in December 2019. EvidenceExpand
The various disguises of mutant SARS-CoV-2 forms and their apparent differences from the original strain are examined as they could possibly aid in finding clinical therapeutic approaches. Expand
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
  • Weilin Zhou, Wei Wang
  • Medicine
  • Signal Transduction and Targeted Therapy
  • 2021
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still threatening global health, and it is speculated that the emergence of the SARS- covirus 2 variants may portend a new phase of the pandemic. Expand
SARS-CoV-2 Mutations and their Viral Variants
Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occur spontaneously during replication. Thousands of mutations have accumulated and continue to since the emergence ofExpand
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
The literature on variants that have currently emerged, and their effect on vaccines and therapies, and, in particular, monoclonal antibodies (mAbs), are reviewed to allow effective preventive and curative control strategies to be developed. Expand
Genomic epidemiology of SARS-CoV-2 divulge B.1, B.1.36, and B.1.1.7 as the most dominant lineages in first, second, and third wave of SARS-CoV-2 infections in Pakistan
It is suggested that these VOCs should be contained at the earliest in order to prevent any devastating outbreak of SARS-CoV-2 in the country. Expand


Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic
It is suggested that SARS-CoV-2 genomes in Los Angeles were predominantly related to the isolates originating from Europe, which are similar to viral strain distributions in New York, New York; a smaller subgroup of Sars- CoV- 2 genomes shared similarities to those from originating from Asia, indicating multiple sources of viral introduction within the Los Angeles community. Expand
S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the US.
Analysis of RT-PCR SARS-CoV-2 tests performed at Helix identifies a rise in S gene dropout in the US starting in early October, and sees a recent expansion in the Eastern part of the US, concentrated in MA, OH, and FL. Expand
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
This work maps how convalescent serum antibodies are impacted by all mutations to the spike’s receptor-binding domain (RBD), the main target of serum neutralizing activity, and can inform surveillance of SARS-CoV-2 evolution. Expand
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
  • Qianqian Li, Jiajing Wu, +17 authors Youchun Wang
  • Biology, Medicine
  • Cell
  • 2020
Most variants with amino acid change at receptor binding domain were less infectious but variants including A475V, L452R, V483A and F490L became resistant to some neutralizing antibodies, while deletion of both N331 and N343 glycosylation drastically reduced infectivity, revealing the importance of gly cosylation for viral infectivity. Expand
GISAID: Global initiative on sharing all influenza data – from vision to reality
  • Y. Shu, J. McCauley
  • Business, Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2017
This poster presents a poster presenting a poster presented at the 2016 International Conference of the Association for the Study of Viral Influenza and its Disruption in China, where it was presented for the first time. Expand